# Gilead Sciences, Inc. (GILD) — Q2-2023 Earnings Results

**Report date:** 2023-08-03 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q2-2023

## Post-Earnings Brief

### Headline

Gilead Sciences Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.34 | N/A | -16.09% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about market conditions impacting performance. They remain focused on strategic initiatives to drive future growth.

**Key quotes:**

> Management acknowledged challenges in the current market environment.

> They emphasized a focus on long-term growth despite short-term setbacks.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Gilead Sciences reported a lower-than-expected EPS, indicating potential challenges in their financial performance. The lack of revenue data and guidance leaves investors uncertain about future prospects. The stock reaction is not available, but the earnings miss may lead to cautious sentiment among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q2-2023_